Turkish Journal of Chemistry
Volume 46

Number 3

Article 14

1-1-2022

Synthesis and in vitro α-glucosidase
-glucosidase and cholinesterases
inhibitory actions of watersolublemetallophthalocyanines bearing
({6-[3-(diethylamino)phenoxy]hexyl}oxy groups
TURGUT KELEŞ
ZEKERİYA BIYIKLIOĞLU
DİDEM AKKAYA
ARZU ÖZEL
BURAK BARUT

Follow this and additional works at: https://journals.tubitak.gov.tr/chem
Part of the Chemistry Commons

Recommended Citation
KELEŞ, TURGUT; BIYIKLIOĞLU, ZEKERİYA; AKKAYA, DİDEM; ÖZEL, ARZU; and BARUT, BURAK (2022)
"Synthesis and in vitro α-glucosidase and cholinesterases inhibitory actions of
watersolublemetallophthalocyanines bearing ({6-[3-(diethylamino)phenoxy]hexyl}oxy groups," Turkish
Journal of Chemistry: Vol. 46: No. 3, Article 14. https://doi.org/10.55730/1300-0527.3368
Available at: https://journals.tubitak.gov.tr/chem/vol46/iss3/14

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Chemistry by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Chemistry

Turk J Chem
(2022) 46: 786-795
© TÜBİTAK
10.55730/1300-0527.3368

http://journals.tubitak.gov.tr/chem/

Research Article

Synthesis and in vitro α-glucosidase and cholinesterases inhibitory actions of watersoluble metallophthalocyanines bearing ({6-[3-(diethylamino)phenoxy]hexyl}oxy groups
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Abstract: In this paper, we have prepared peripherally tetra-({6-[3-(diethylamino)phenoxy]hexyl}oxy substituted cobalt(II), copper(II),
manganese(III) phthalocyanines (3, 4, 5) and their water-soluble derivatives (3a, 4a, 5a). Then, in vitro α-glucosidase and cholinesterases
inhibitory actions of the water-soluble 3a, 4a, 5a were examined using spectrophotometric methods. 4a had the highest inhibitory
effects among the tested compounds against α-glucosidase due to IC50 values. 4a and 5a had 40 fold higher inhibitory effects than the
positive control. For cholinesterases, the compounds showed significant inhibitory actions that of galantamine which was used as a
positive control. According to the SI value, 3a inhibited acetylcholinesterase enzyme selectively. In kinetic studies, 4a was a mixed
inhibitor for α-glucosidase, 3a was a competitive inhibitor for AChE, and 4a was a mixed inhibitor for BuChE. The therapeutic potential
of these compounds has been demonstrated by in vitro studies, but these data should be supported by further studies.
Key words: Phthalocyanine, water-soluble, cholinesterases, α-Glucosidase, enzyme kinetic

1. Introduction
Diabetes Mellitus (DM), which is a metabolic disease that occurs in advanced ages and is characterized by hyperglycemia,
causes health complications such as retinopathy, nephropathy, cardiovascular disease, and obesity [1,2]. Controlling
hyperglycemia and regulating blood sugar levels are the most important targets for this metabolic disease [3,4]. One
of the most important approaches used in the treatment of DM is the inhibition of the α-glucosidase enzyme, which
breaks down polysaccharides into smaller saccharides. With the inhibition of α-glucosidase, the hydrolysis of food-derived
sugar is prevented, thereby controlling the blood sugar level and regulating postprandial hyperglycemia [5,6]. Although
α-glucosidase inhibitors such as acarbose, miglitol, and voglibose are currently used in the treatment, various side effects
such as nausea, diarrhea, and gastrointestinal discomfort are observed in the clinic [7,8]. The search for alternative
α-glucosidase inhibitors to these drugs, which are less costly and have fewer side effects, continues [9,10].
Alzheimer’s disease (AD), is one of the neurodegenerative diseases that progresses over time and has limited treatment
[11,12]. This disease causes memory, learning loss, and selective/irreversible impairments that occur in cholinergic
function. This is called the “cholinergic hypothesis” in the pathogenesis of AD [13,14]. Acetylcholinesterase (AChE) and
butyrylcholinesterase (BuChE) enzymes, which are responsible for the termination of the neurotransmission signal in
the cholinergic hypothesis associated with learning and memory function, perform this task by hydrolyzing acetylcholine
(ACh) to choline and acetic acid. Low ACh levels are a condition that should be treated in AD [15,16]. Today, cholinesterase
(ChE) inhibitors such as galantamine, rivastigmine, donepezil, and tacrine are used for AD in clinic. However, its clinical
usage has been limited due to various side effects such as hepatotoxicity, gastrointestinal system disorders, and hypotension
arising [17,18].
Phthalocyanines have been used in various biological and industrial areas such as photodynamic therapy [19],
anticancer agents [20], organic photovoltaic devices [21], liquid crystals [22], electrochromic display devices [23], solar
cell [24], electrocatalytic agents [25] owing to their chemical and physical properties. Also, there are many studies on
the α-glucosidase and cholinesterase inhibitory effects of phthalocyanines in the literature [26,27]. Diethylamino
groups are widely preferred as substituted groups on water-soluble phthalocyanines, as they have both biological and
pharmacological importance and contain nitrogen atoms that can be quaternized [28,29]. For this reason, the aim of this
* Correspondence: zekeriyab@ktu.edu.tr
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study is to determine the in vitro α-glucosidase and cholinesterases inhibitory effects of water-soluble cobalt(II), copper(II),
manganese(III) phthalocyanines bearing peripherally tetra-({6-[3-(diethylamino)phenoxy]hexyl}oxy groups.
2. Experimental
The used materials, equipment, and in vitro inhibition assay on α-glucosidase, AChE, and BuChE are given in supplementary
information.		
2.1. Synthesis
2.1.1. 4-({6-[3-(Diethylamino)phenoxy]hexyl}oxy)phthalonitrile (2)
6-[3-(Diethylamino)phenoxy]hexan-1-ol (1) (1 g, 3.78 mmol), 4-nitrophthalonitrile (0.65 g, 3.78 mmol), dry K2CO3 (1.6
g, 11.34 mmol) were dissolved in DMF (15 mL) at 60 °C under N2 atmosphere for 4 days. Then, reaction mixture was
poured into water (200 mL) and stirred for 3 h. After that, the aqueous phase extracted with chloroform (3 × 50 mL). The
combined extracts were dried over anhydrous MgSO4 and then filtered. The product was purified by aluminum oxide column
chromatography using CHCl3. Yield: 0.5 g (34%). IR (ATR), ν/cm−1: 3075 (Ar–H), 2942–2870 (Aliph. C–H), 2230 (C ≡ N),
1598, 1501, 1473, 1394, 1315, 1281, 1255, 1213, 1169, 1096, 1022, 919, 803, 758. 1H NMR (400 MHz, DMSO-d6), (δ): 8.01 (d,
1H, Ar-H), 7.72 (s, 1H, Ar–H), 7.42 (d, 1H, Ar–H), 6.98 (t, 1H, Ar–H), 6.22 (d, 1H, Ar–H), 6.12–6.08 (m, 2H, Ar-H), 4.11
(t, 2H, CH2–O), 3.88 (t, 2H, CH2–O), 3.28–3.23 (q, 4H, –CH2-N), 1.73–1.66 (m, 4H, –CH2-), 1.45–1.39 (m, 4H, –CH2-), 1.05
(t, 6H, CH3). 13C-NMR (100 MHz, DMSO-d6), (δ): 162.48, 160.39, 149.14, 136.16, 130.19, 120.66, 120.46, 116.70, 116.68,
116.17, 106.16, 105.00, 101.20, 98.61, 69.41, 67.30, 44.09, 29.19, 28.61, 25.69, 25.52, 12.88. MS (ESI), (m/z) calcl. 391.50;
found: 391.70 [M]+.
2.1.2. The synthesis procedure of metallophthalocyanines (3, 4, 5)
4-({6-[3-(Diethylamino)phenoxy]hexyl}oxy)phthalonitrile (2) (100 mg, 0.25 mmol), 0.12 mmol related metal salts (16 mg
CoCl2, 16 mg CuCl2, 17 mg MnCl2) in 1-pentanol (2 mL) and 1,8-diazabycyclo [5.4.0]undec-7-ene (DBU) (3 drops) was
heated at 160 °C for 1 day. The product was precipitated with n-hexane. Finally, (3, 4, 5) were purified by aluminum oxide
column chromatography using CHCl3.
2.1.3. Cobalt(II) phthalocyanine (3)
Yield: 20 mg (20%), m.p. >250 ºC. IR (ATR), ν/cm−1: 3066 (Ar–H), 2920–2850 (Aliph. C–H), 1729, 1607, 11497, 1488, 1467,
1357, 1232, 1214, 1178, 1094, 820, 748, 654. UV–Vis (DMF) λmax nm (log ε): 668 (4.93), 609 (4.51), 328 (4.92). MALDITOF-MS m/z calc. 1624.95; found: 1624.56 [M]+.
2.1.4. Copper(II) phthalocyanine (4)
Yield: 26 mg (26%), m.p. > 250 ºC. IR (ATR), ν/cm−1: 3071-3038 (Ar–H), 2968–2855 (Aliph. C–H), 1607, 1570, 1498, 1465,
1388, 1343, 1238, 1214, 1119, 1093, 956, 820, 745, 687. UV–Vis (DMF) λmax nm (log ε): 680 (5.02), 617 (4.679), 341 (4.86).
MALDI-TOF-MS m/z calc. 1629.57; found: 1629.28 [M]+.
2.1.5. Manganese(III) phthalocyanine chloride (5)
Yield: 50 mg (47%), m.p. > 250 ºC. IR (ATR), ν/cm−1: 3071 (Ar–H), 2926–2858 (Aliph. C–H), 1603, 1496, 1464, 1341, 1240,
1214, 1123, 1074, 1052, 821, 745, 686. UV–Vis (DMF) λmax nm (log ε): 729 (4.98), 652 (4.59), 500 (4.36), 355 (4.85). MALDITOF-MS m/z calc. 1656.41; found: 1621.35 [M-Cl]+.
2.1.6. The synthesis procedure of water-soluble metallophthalocyanines (3a, 4a, 5a)
3a (20 mg, 0.012 mmol), 4a (20 mg, 0.016 mmol), 5a (20 mg, 0.012 mmol) was dissolved in CHCl3 (2.5 mL), added
iodomethane (2 mL) and stirred at rt for 4 days. The precipitated products were filtered and washed with CHCl3, diethyl ether.
2.1.7. Water-soluble cobalt(II) phthalocyanine (3a)
Yield: 19 mg (70%), m.p. > 250 ºC. IR (ATR), ν/cm−1: 3061 (Ar–H), 2932–2859 (Aliph. C–H), 1713, 1606, 1456, 1408, 1337,
1231, 1116, 1092, 1060, 1006, 870, 823, 750. UV-Vis (DMF), λmaks (loge) nm : 671 (4.94), 608 (4.48), 327 (4.85). MALDI-TOFMS m/z calc. 2192.71; found: 421.12 [M-4I]+4.
2.1.8. Water-soluble copper(II) phthalocyanine (4a)
Yield: 20 mg (74%), m.p. > 250 ºC. IR (ATR), ν/cm−1: 3013 (Ar–H), 2934–2860 (Aliph. C–H), 1607, 1487, 1457, 1390, 1232,
1090, 1053, 1005, 870, 745, 689. UV-Vis (DMF), λmaks (loge) nm : 680 (5.03), 612 (4.44), 345 (4.70). MALDI-TOF-MS m/z
calc. 2197.32; found: 422.24 [M-4I]+4.
2.1.9. Water-soluble manganese(III) phthalocyanine chloride (5a)
Yield: 17 mg (65%), m.p. > 250 ºC. IR (ATR), ν/cm−1: 3019 (Ar–H), 2933–2860 (Aliph. C–H), 1602, 1457, 1391, 1338, 1235,
1119, 1054, 993, 1054, 999, 869, 745, 691. UV-Vis (DMF), λmaks (loge) nm : 728 (5.01), 661 (4.55), 500 (4.37), 367 (4.85).
MALDI-TOF-MS m/z calc. 2224.17; found: 420.12 [M-Cl-4I]+4.

787

KELEŞ et al. / Turk J Chem
3. Results and discussion
3.1. Synthesis and characterization
The synthesis of peripherally tetra-({6-[3-(diethylamino)phenoxy]hexyl}oxy) group substituted metallophthalocyanines
and their water-soluble derivatives are given in Figure 1 and 2. 4-({6-[3-(Diethylamino)phenoxy]hexyl}oxy)phthalonitrile
(2) was prepared by the reaction of 6-[3-(diethylamino)phenoxy]hexan-1-ol (1) [30] and 4-nitrophthalonitrile in DMF at
60 °C. Cobalt(II), copper(II), and manganese(III) phthalocyanines (3, 4, 5) were synthesized by reaction of 2 and metal
salts in 1-pentanol. Then, water-soluble phthalocyanines (3a, 4a, 5a) were prepared by reaction of cobalt(II), copper(II),
and manganese(III) phthalocyanines (3, 4, 5) with iodomethane at room temperature [31,32]. In the IR spectrum of 2,
the new vibration belonging to C ≡ N group appeared as expected. In the 1H-NMR spectrum of 2, aromatic protons were
observed at δ 8.01–6.08 ppm. Also, CH2–O (4.11, 3.88 ppm), CH2-N (3.28-3.23), and –CH3 (1.05 ppm) protons were
seen as expected. In the 13C-NMR spectrum of 2, the nitrile group of carbon atom resonances was seen between 116.70
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Figure 1. Synthesis of metallophthalocyanines. (i) K2CO3, 60 °C, DMF. (ii) CoCl2, CuCl2,
MnCl2, 1-pentanol, DBU, 160 °C.
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and 116.17 ppm. In the mass spectrum of 4-({6-[3-(diethylamino)phenoxy]hexyl}oxy)phthalonitrile (2), the [M]+ peak
at 391.70 verified the suggested structure. In the IR spectra of (3, 4, 5), the sharp –C ≡ N vibrations of 2 disappeared as
expected. The 1H-NMR spectra of (3, 4, 5) could not be recorded due to the paramagnetic metal ions in the ring center
[33]. Also, the IR spectra of (3a, 4a, 5a) were very similar to (3, 4, 5). In the MALDI–TOF–MS of (3, 4, 5) the presence
of the molecular ion peaks at m/z = 1624.56 [M]+, m/z = 1629.28 [M]+, m/z = 1621.35 [M-Cl]+ confirmed the proposed
structure, respectively. On the other hand, the [(M-4I)/4]+ signals were observed at 421.12 [(M-4I)/4]+, 422.24 [(M-4I)/4]+
and 420.12 [(M-Cl-4I)/4]+ in mass spectra, supported the proposed structures of water-soluble (3a, 4a, 5a), respectively.
The electronic absorption spectra of (3, 4, 5) and (3a, 4a, 5a) in DMF at room temperature are shown in Figure 3. As shown
in Figure 3, the Q bands were observed as single and narrow bands at ~1x10-5 M. These bands confirm the monomeric
behavior of the metallophthalocyanines (MPcs). The absorption spectra of (3, 4, 5) and (3a, 4a, 5a) displayed Q bands
at 668, 680, 729, 671, 680, 728 nm, respectively. The B (Soret) bands of (3, 4, 5) and (3a, 4a, 5a) were observed at 328,
341, 355, 327, 345, 367 nm, respectively. All spectral data confirmed the suggested structure of cobalt(II), copper(II), and
manganese(III) phthalocyanines (3, 4, 5) and their water-soluble derivatives (3a, 4a, 5a).
3.2. Inhibition study of α-glucosidase
In this study, in vitro anti-α-glucosidase effects the compounds 3a, 4a, 5a were investigated by spectrophotometric
methods. Acarbose was used as a positive control. The results were tabulated as IC50 values in Table 1. All of the compounds
showed higher inhibitory effects on α-glucosidase than that of acarbose (IC50 = 60.28 ± 3.42 µM). 4a has the best inhibitory
actions with 1.36 ± 0.01 µM of IC50 value among the tested compounds. 4a and 5a had an inhibitory activity about 40
times higher inhibitory activity than that of acarbose. According to the literature, Güzel et al. investigated inhibitory
effects of peripheral furan-2-ylmethoxy-substituted copper and manganese phthalocyanines on α-glucosidase [26]. The
IC50 values of these compounds were determined as 911.20 µM and 695.37 µM, respectively. The peripherally tetra-({6-[3(diethylamino)phenoxy]hexyl}oxy substituted cobalt(II), copper(II), manganese(III) phthalocyanines displayed a higher
inhibitory effect on α-glucosidase than that of furan-2-ylmethoxy-substituted compounds on α-glucosidase, according to
the IC50 values.
In this work, Lineweaver-Burk and Dixon plots were investigated to evaluate the inhibitory type and inhibition
constant (Ki) for 4a which had the best inhibitory actions on α-glucosidase. The results are given in Table 2 and Figure 4.
On enhancing substrate and inhibitors concentrations against α-glucosidase, Vmax (maximum rate) value diminished and
Km value increased. This result claimed that the compound inhibited the enzyme via mixed inhibition.
3.3. Inhibition studies of AChE and BuChE
The in vitro antiChEs actions of all synthesized compounds were investigated to determine their therapeutic potential in
AD. Galantamine was used as a positive control. The results are shown in Table 3. The results showed that the compounds
have higher inhibition efficiency on AChE and BuChE when compared to galantamine (IC50 = 30.20 ± 0.58 µM for AChE
and 52.04 ± 0.55 µM for BuChE). The IC50 values of 3a, 4a, 5a were 0.65 ± 0.01 µM, 1.08 ± 0.03 µM, and 1.35 ± 0.01 µM,
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Figure 3. UV-vis spectra of 3, 4, 5 (a) and 3a, 4a, 5a (b) in DMF.
Table 1. IC50 values of the compounds on α-glucosidase.
α-Glucosidase
3a

2.48 ± 0.04***

4a

1.36 ± 0.01***

5a

1.49 ± 0.02***

Acarbose

60.28 ± 3.42

*** p < 0.0001 vs. positive control
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Table 2. Kinetic parameters of the compounds on AChE, BuChE, and α-glucosidase.
α-Glucosidase

AChE

BuChE

Type

Ki

Type

Ki

Type

Ki

3a

-

-

competitive

0.51 ± 0.04

-

-

4a

mixed

0.49 ± 0.03

-

-

mixed

0.05 ± 0.01

Figure 4. Lineweaver-Burk (a) and Dixon (b) plots of 4a on α-glucosidase.
Table 3. IC50 and SI values of the compounds on AChE, BuChE.
AChE

BuChE

SI values (BuChE/AChE)

3a

0.65 ± 0.01***

3.06 ± 0.02***

4.70

4a

1.08 ± 0.03***

0.29 ± 0.01***

0.27

5a

1.35 ± 0.01***

3.57 ± 0.03***

2.42

Galantamine

30.20 ± 0.58

52.04 ± 0.55

1.72

*** p < 0.0001 vs. positive control
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respectively on AChE. In addition, the compounds displayed significant BuChE inhibitory properties that of galantamine
(p < 0.0001). 4a had the best BuChE inhibitory actions with 0.29 ± 0.01 µM of IC50 value following 3a with 3.06 ± 0.02
µM of IC50 value. According to the SI (selective index (IC50 = BuChE/IC50 = AChE)) values, 3a inhibited AChE selectively
(SI value = 4.70). The difference in the results is thought to be due to the metal effect. Frasco et al. reported the metals
inhibitory effects of different metals (copper, nickel, zinc, cadmium, and mercury) on AChE [34]. The results showed that
copper, zinc, cadmium, and mercury inhibited on AChE [34].
In literature, Arslan reported novel peripherally tetra-chalcone substituted metal-free, manganese, cobalt and copper
phthalocyanines and their inhibitory effects against AChE [34]. These compounds had lower inhibitory effects than
neostigmine (IC50 = 0.136 ± 0.011 µM) which was used as a positive control but 3a showed higher inhibitory actions about
46 times than galantamine on AChE [35]. In our previous study, the ChEs inhibitory effects of peripheral or nonperipheral
tetra-[4-(9H-carbazol-9-yl)phenoxy] substituted cobalt, manganese phthalocyanines were investigated and IC50 values of
these compounds were determined ranging from 7.39 ± 0.25 µM to 58.02 ± 4.94 µM [36]. The compounds used in this
study were found to be more effective when compared to our previous study according to the IC50 values [36].
In kinetic analysis, 3a showed competitive inhibition with Vmax unchanged and Km increased on AChE, according to
the Lineweaver-Burk plot (Figure 5a). On the other hand, 3a was a mixed inhibitor due to the change of Vmax and Km values
toward BuChE (Figure 6a). Ki values of the compounds were determined as 0.51 ± 0.04 µM for 3a and 0.05 ± 0.01 µM for
4a, respectively (Figures 5b and 6b).
4. Conclusion
In this work, we have synthesized and characterized peripherally tetra-({6-[3-(diethylamino)phenoxy]hexyl}oxy)
substituted metallophthalocyanines (3, 4, 5) and their water-soluble derivatives (3a, 4a, 5a). Also, we have reported

Figure 5. Lineweaver-Burk (a) and Dixon (b) plots of 3a on AChE.
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Figure 6. Lineweaver-Burk (a) and Dixon (b) plots of 4a on BuChE.

α-glucosidase and ChEs inhibitory actions of 3a, 4a, 5a using spectrophotometric methods. All compounds had significant
inhibitory properties on α-glucosidase and ChEs. According to the IC50 values, 4a had the highest inhibitory effects among
the tested compounds against α-glucosidase. 4a and 5a showed 40 fold higher inhibitory effects than acarbose. In ChEs
studies, the compounds had significant inhibitory actions when compared to galantamine (p < 0.0001). 3a inhibited the
AChE enzyme selectively, according to the SI value. In kinetic studies, 4a was a mixed inhibitor for α-glucosidase, 3a was
a competitive inhibitor for AChE, and 4a was a mixed inhibitor for BuChE. Although it has been determined that these
compounds have potential against DM and AD treatments in vitro, these data should be supported by further studies.
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Supplementary Information
1. Materials and methods
All reagents and solvents were of reagent grade quality and were obtained from commercial suppliers. Acarbose (Sigma,
A8980), acetylcholinesterase (AChE) from Electrophorus electricus (electric eel) (Sigma, C3389), acetylthiocholine iodide
(AChI) (Sigma, A5751), butyrylcholinesterase (BuChE) from equine serum (Sigma, C1057), butyrylthiocholine iodide
(BChI) (Sigma, 20820), 5,5-dithio-bis(2-nitrobenzoic)acid (DTNB) (Sigma, D8130), galantamine (Sigma, 1287755), α-1,4glucosidase from Saccharomyces cerevisiae (Sigma, G5003), and p-nitrophenyl-α-glucopyranoside (4-pNPG) (Sigma,
487506) were obtained from commercial sources. The inhibitory effects of the enzymes were performed using Thermo
Scientific MultiskanTM Go Microplate Spectrophotometer using a 96-well microplate reader.
2. α-Glucosidase inhibition assay
α-Glucosidase inhibition assay was performed as previously reported with some modifications [1]. Acarbose was used
as a positive control, and DMSO (final concentration .8%) as blank. The compounds (50 µL) in phosphate buffer pH 6.9,
α-glucosidase (100 µL, 0.5 U/mL) were added and allowed to react for 20 min in a microplate. After incubation, 4-pNPG
(50 µL, 5 mM) was added and incubated for 20 min at room temperature. The absorbance was measured at 405 nm using
a 96-well microplate reader. α-glucosidase inhibition percentage of the compounds was calculated using formula 1.
3. In vitro AChE and BuChE inhibition assay
The in vitro AChE and BuChE inhibition actions were measured according to our previous method with some modifications
[2]. Galantamine was used as a positive control and DMSO (final concentration 0.8%) as blank. Tris-HCl buffer (50 µL,
50 mM pH 8), DTNB (125 µL, 3 mM), AChE/BuChE (25 µL, 0.2 U/mL), and the compounds were added into the plate
and incubated for 15 min at room temperature. Then, 25 µL of 15 mM of the substrate (AChI/BChI) was added into the
plate to begin an enzymatic reaction. The absorbance was measured at 412 nm. AChE and BuChE inhibition percentage
of the compounds was calculated using the formula. Formula = % Inhibition: ((Acontrol-A)/Acontrol) × 100. Acontrol is the
activity of the enzyme without compound and A is the activity of the enzyme with compound. The inhibitory effect of the
compounds was expressed as the concentration which inhibited 50% of the enzyme activity (IC50).
4. Kinetic analysis
Lineweaver-Burk and Dixon plots were performed to examine kinetic parameters (inhibitory type and constant (Ki) values)
of the compounds against enzymes [3,4]. The kinetic analysis was conducted by increasing substrate concentrations in
the absence and presence of the compounds. The method was analyzed according to the procedures described above for
α-glucosidase and cholinesterases.
5. Statistical analysis
Statistical analysis was performed using Microsoft Excel Windows 10 and GraphPad Prism 5.0. The results were expressed
as mean ± standard deviation (n = 3). Statistical analysis was performed by one-way analysis of variance (ANOVA)
followed by Tukey’s tests.
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